Venetoclax combined with three-day multi-frequency decitabine (DEC3-VEN) in elder or intensive chemotherapy ineligible patients with newly diagnosed acute myeloid leukemia - Xiaohui Suo; Xiaojun Ma; Fang Zheng; Dongmei Wang; Guanchen Bai; Liyun Zhao; Zhongjing Han; Xin Lv; Congcong Zhang; Ju Wang; Kangxin Tuo; Zhen Meng; et al. (Blood Cancer Journal)